By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

Victorian brain cancer researchers have achieved a global-first, using an innovative process to learn how a new drug ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

Vascular toxicity associated with cancer therapies is a leading cause of cardiovascular adverse events in patients with ...

H LUNDBECK A/S (($HLUYY)) announced an update on their ongoing clinical study. H. Lundbeck A/S is currently conducting a clinical trial titled ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

HBAR could recover above $0.25 amid SWIFT blockchain trials, but the current market correction could affect its comeback.

The reporting methods of noninferiority randomized clinical trials are often inconsistent, with many publications omitting ...

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...

More than two years after the Food and Drug Administration held a public workshop on measuring overall survival (OS) in ...

While smoking rates in the United States have substantially declined over the past six decades, smoking remains high among ...